V-Wave kicks off enrollment in pivotal study of device for HF Oct. 4, 2018 By Liz Hollis Israeli startup V-Wave Ltd. reported the start of enrollment in a study of a minimally invasive device to treat patients with New York Heart Association (NYHA) class III and ambulatory class IV symptomatic heart failure (HF). Read More
Lungvision launch seen as step towards winning battle against lung cancer Oct. 4, 2018 By Ned Stafford
Checkpoint inhibition work earns Nobel for Kyoto's Honjo, MD Anderson's Allison Oct. 3, 2018 By Nuala Moran
RSS